Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC
Cytopathology · 2023-03 · 34 (2) · 165-168
DOI: 10.1111/cyt.13190 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cytopathology, online erschienen am 07.12.2022. Verfasst von Veronika Kloboves Prevodnik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cytopathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
- Department of Pathology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
ORCID-Profile: Veronika Kloboves Prevodnik
Zitieren
APA
Prevodnik, V. K., & Gašljević, G. (2023). Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC. Cytopathology, 34(2), 165-168. https://doi.org/10.1111/cyt.13190
Vancouver
Prevodnik VK, Gašljević G. Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC. Cytopathology. 2023;34(2):165-168. doi:10.1111/cyt.13190
BibTeX
@article{Prevodnik2023,
author = {Prevodnik, Veronika Kloboves and Gašljević, Gorana},
title = {Cytokeratin and CD56 aberrant co‐expression in diffuse large B‐cell lymphoma, NOS misinterpreted as metastatic neuroendocrine carcinoma by FNAC},
journal = {Cytopathology},
year = {2023},
volume = {34},
number = {2},
pages = {165--168},
doi = {10.1111/cyt.13190}
}
EUVIMED